Privia Health Group (NASDAQ:PRVA) Reaches New 12-Month High – Time to Buy?

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $25.49 and last traded at $25.47, with a volume of 764095 shares trading hands. The stock had previously closed at $24.87.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on PRVA shares. Truist Financial increased their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Stephens reiterated an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. JMP Securities reissued a “market outperform” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Friday, February 14th. Macquarie started coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective for the company. Finally, Barclays lifted their price objective on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $24.94.

Privia Health Group Stock Down 3.4 %

The stock has a market cap of $2.96 billion, a PE ratio of 246.42, a PEG ratio of 3.53 and a beta of 0.87. The stock’s fifty day moving average price is $21.85 and its 200 day moving average price is $20.33.

Institutional Trading of Privia Health Group

Institutional investors and hedge funds have recently modified their holdings of the business. Creative Planning increased its holdings in Privia Health Group by 27.1% in the 3rd quarter. Creative Planning now owns 25,987 shares of the company’s stock worth $473,000 after buying an additional 5,542 shares in the last quarter. Everence Capital Management Inc. purchased a new position in shares of Privia Health Group during the third quarter valued at approximately $218,000. Sequoia Financial Advisors LLC raised its holdings in shares of Privia Health Group by 2.3% during the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after purchasing an additional 583 shares during the last quarter. Guidance Capital Inc. lifted its position in Privia Health Group by 7.7% during the third quarter. Guidance Capital Inc. now owns 25,663 shares of the company’s stock valued at $458,000 after purchasing an additional 1,835 shares during the period. Finally, International Assets Investment Management LLC boosted its holdings in Privia Health Group by 1,720.9% in the third quarter. International Assets Investment Management LLC now owns 5,499 shares of the company’s stock worth $100,000 after purchasing an additional 5,197 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.